Joseph Baroldi, the EVP of $IONS, sold 5,635 shares of the company on 06-26-2026 for an estimated $451,698. We received data on the trade from a recent SEC filing. This was a sale of approximately 54.7% of their shares of this class of stock. Following this trade, they now own 4,669 shares of this class of $IONS stock.
$IONS Insider Trading Activity
$IONS insiders have traded $IONS stock on the open market 85 times in the past 6 months. Of those trades, 0 have been purchases and 85 have been sales.
Here’s a breakdown of recent trading of $IONS stock by insiders over the last 6 months:
- BRETT P MONIA (Chief Executive Officer) has made 0 purchases and 8 sales selling 226,607 shares for an estimated $18,209,959.
- ELIZABETH L HOUGEN (EVP, Finance & CFO) has made 0 purchases and 5 sales selling 245,130 shares for an estimated $17,867,370.
- C FRANK BENNETT (EVP, Chief Scientific Officer) has made 0 purchases and 8 sales selling 185,040 shares for an estimated $14,960,646.
- SHANNON L. DEVERS (EVP, Chief Human Resources Ofc) has made 0 purchases and 11 sales selling 82,828 shares for an estimated $6,773,524.
- JOSEPH LOSCALZO has made 0 purchases and 4 sales selling 78,321 shares for an estimated $5,884,059.
- ERIC SWAYZE (EVP Research) has made 0 purchases and 8 sales selling 65,819 shares for an estimated $5,235,559.
- HOLLY B. KORDASIEWICZ (EVP, Chief Development Officer) has made 0 purchases and 3 sales selling 64,987 shares for an estimated $4,779,735.
- ALLENE M. DIAZ has made 0 purchases and 3 sales selling 54,878 shares for an estimated $4,354,428.
- JOSEPH III KLEIN has made 0 purchases and 7 sales selling 53,764 shares for an estimated $4,125,721.
- EUGENE SCHNEIDER (EVP, Chf Clinical Develop Ofcr) has made 0 purchases and 4 sales selling 47,293 shares for an estimated $3,738,450.
- JOSEPH BAROLDI (EVP, Chief Business Officer) has made 0 purchases and 11 sales selling 32,891 shares for an estimated $2,568,005.
- PATRICK R. O'NEIL (EVP CLO & General Counsel) has made 0 purchases and 3 sales selling 18,439 shares for an estimated $1,458,718.
- BRIAN BIRCHLER (EVP, Corp and Development Ops) has made 0 purchases and 3 sales selling 15,632 shares for an estimated $1,222,996.
- SPENCER R BERTHELSEN has made 0 purchases and 2 sales selling 16,000 shares for an estimated $1,193,280.
- B LYNNE PARSHALL has made 0 purchases and 3 sales selling 10,000 shares for an estimated $794,955.
- KYLE JENNE (EVP, Chf GL Pdt Str Ofcr) has made 0 purchases and 2 sales selling 6,725 shares for an estimated $506,963.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$IONS Hedge Fund Activity
We have seen 252 institutional investors add shares of $IONS stock to their portfolio, and 246 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 7,367,066 shares (-56.0%) from their portfolio in Q4 2025, for an estimated $582,808,591
- CAPITAL WORLD INVESTORS added 3,225,070 shares (+18.0%) to their portfolio in Q1 2026, for an estimated $242,170,506
- TWO SIGMA INVESTMENTS, LP added 3,198,983 shares (+120.3%) to their portfolio in Q1 2026, for an estimated $240,211,633
- BELLEVUE GROUP AG removed 2,983,534 shares (-62.1%) from their portfolio in Q1 2026, for an estimated $224,033,568
- ROYAL BANK OF CANADA added 2,683,018 shares (+239.8%) to their portfolio in Q1 2026, for an estimated $201,467,821
- JPMORGAN CHASE & CO added 1,760,324 shares (+323.3%) to their portfolio in Q4 2025, for an estimated $139,259,231
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 1,265,000 shares (-96.2%) from their portfolio in Q1 2026, for an estimated $94,988,850
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$IONS Revenue
$IONS had revenues of $246M in Q1 2026. This is an increase of 86.91% from the same period in the prior year.
You can track IONS financials on Quiver Quantitative's IONS stock page.
You can access data on IONS stock through the Quiver Quantitative API.
$IONS Analyst Ratings
Wall Street analysts have issued reports on $IONS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 04/30/2026
To track analyst ratings and price targets for $IONS, check out Quiver Quantitative's $IONS forecast page.
$IONS Price Targets
Multiple analysts have issued price targets for $IONS recently. We have seen 14 analysts offer price targets for $IONS in the last 6 months, with a median target of $109.0.
Here are some recent targets:
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $130.0 on 06/25/2026
- Salveen Richter from Goldman Sachs set a target price of $75.0 on 06/25/2026
- Mani Foroohar from Leerink Partners set a target price of $129.0 on 06/25/2026
- Yaron Werber from TD Cowen set a target price of $108.0 on 06/15/2026
- Eric Joseph from Citigroup set a target price of $115.0 on 05/19/2026
- Eliana Merle from Barclays set a target price of $115.0 on 04/30/2026
- Luca Issi from RBC Capital set a target price of $100.0 on 04/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
